Balaji Gandhi Sells 28,759 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 28,759 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the transaction, the chief financial officer now directly owns 116,174 shares in the company, valued at approximately $3,485,220. This trade represents a 19.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Stock Performance

NYSE PHR opened at $29.64 on Thursday. The company’s 50 day moving average is $27.14 and its 200-day moving average is $23.77. The firm has a market cap of $1.72 billion, a P/E ratio of -20.16 and a beta of 0.96. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.58) EPS. Sell-side analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Johnson Financial Group Inc. boosted its position in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares during the period. R Squared Ltd purchased a new stake in Phreesia in the 4th quarter worth approximately $30,000. International Assets Investment Management LLC boosted its holdings in Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares during the period. BankPlus Trust Department purchased a new position in shares of Phreesia during the 4th quarter valued at $34,000. Finally, Quarry LP increased its holdings in shares of Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after purchasing an additional 1,923 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on PHR shares. Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Piper Sandler restated an “overweight” rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. KeyCorp increased their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Thirteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.